Consistent with the pathogenic role of dysregulated type I IFN production, human gain-of-function mutations in STING lead to systemic inflammation (6, 7), whereas excessive cGAS-STING signaling in response to either self or pathogen DNA is now linked to multiple diseases, including cancers (8). Here, STING1 is linked to cancer.